Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

OPNT

Opiant Pharmaceuticals (OPNT)

Opiant Pharmaceuticals Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:OPNT
DatumZeitQuelleÜberschriftSymbolFirma
02/11/201211h04Edgar (US Regulatory)Filing of certain prospectuses and communications in connection with business combination transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h04Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Mutual Fund Summary Prospectus (497k)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
02/11/201211h03Edgar (US Regulatory)Filing of Certain Prospectuses and Communications in Connection With Business Combination Transactions (425)NASDAQ:OPNTOpiant Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:OPNT